BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DEMENTIA RESEARCHER - ECPv6.14.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DEMENTIA RESEARCHER
X-ORIGINAL-URL:https://www.dementiaresearcher.nihr.ac.uk
X-WR-CALDESC:Events for DEMENTIA RESEARCHER
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260707
DTEND;VALUE=DATE:20260711
DTSTAMP:20260621T203155
CREATED:20260519T164852Z
LAST-MODIFIED:20260519T164852Z
UID:10002251-1783382400-1783727999@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Dementia UK Annual Summer School
DESCRIPTION:Tuesday 7th-Friday 10th July 2026 \nDementia UK is excited to host its free annual Summer School\, with the aim of improving practice in and knowledge of dementia care. \nWe invite all health and social care practitioners\, including students\, volunteer sector workers and allied professionals who have an interest in improving care and support for families living with dementia. \nOn this page\, you will find a description of the topics available during Summer School 2026 and links to registration forms. You are welcome to book as many or as few webinars as you like. \nIf you have any questions\, please contact ANacademy@dementiauk.org \n\nTuesday 7th July 2026\n10.30am-12pm Welcome to Dementia UK and Admiral Nursing \n\nWelcome to Dementia UK: the specialist dementia nursing charity\nAdmiral Nurses working across different settings\n\nRegister for this session \n2-4pm Practical tips and advice in dementia care \n\nTop tips from dementia carers: Lived Experience Advisory Panel (LEAP) discussion around risks in the home\nRisks in the home\n\nRegister for this session \nWednesday 8th July 2026\n10.30am-12pm Rarer types of dementia and tackling stigma  \n\nFrontotemporal dementia\nTackling the stigma in young onset dementia\n\nRegister for this session \n2-4pm Parkinson’s and Lewy body dementia \n\nParkinson’s and cognition: symptom management and treatment\nLewy body dementia: understanding the lived experience and supporting families – what works\n\nRegister for this session \nThursday 9th July 2026\n10.30am-12pm Honouring and supporting the LGTBQ+ community and dementia care \n\nLove\, legacy and memory: centring LGBTQ+ stories in dementia care\n\nRegister for this session \n2-4pm Honouring culturally responsive dementia care \n\nInclusive dementia care: cultural and religious considerations\nProtocols used in transcultural dementia care: supporting communities from diverse backgrounds\n\nRegister for this session \nFriday 10th July 2026\n10.30am-12.30pm Intimacy and sensory needs  \n\nPromoting intimacy in dementia care\nHearing loss and dementia: why hearing matters for brain health\nNavigating the complexity of real life: a family experience\n\nRegister for this session \nAll presentations are recorded and available on the Dementia UK YouTube channel.
URL:https://www.dementiaresearcher.nihr.ac.uk/event/dementia-uk-annual-summer-school/
LOCATION:Online\, United Kingdom
CATEGORIES:Training
ATTACH;FMTTYPE=image/jpeg:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2022/06/Dementia-UK-e1655884462548.jpg
ORGANIZER;CN="Dementia UK":MAILTO:info@dementiauk.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260708T090000
DTEND;TZID=Europe/London:20260708T100000
DTSTAMP:20260621T203155
CREATED:20260618T201957Z
LAST-MODIFIED:20260618T201957Z
UID:10002291-1783501200-1783504800@www.dementiaresearcher.nihr.ac.uk
SUMMARY:UKDTN/ARUK - Clinical Trial Placement Pilot Programme
DESCRIPTION:The National Institute for Health and Care Research (NIHR) UK Dementia Trials Network (UKDTN) and Alzheimer’s Research UK (ARUK) are hosting a webinar to explore the Clinical Trial Placement Pilot Programme\, an optional component of the ARUK Doctoral Clinical Fellowship Programme. \nThis exciting opportunity is designed to give aspiring clinical academics hands-on experience in dementia clinical trials\, with the aim of developing future leaders in clinical trial research. The session will include short presentations introducing UKDTN’s mission and strategic goals by Professor John-Paul Taylor\, alongside an overview of the ARUK Doctoral Clinical Fellowship programme and placement opportunity\, presented by Eve Chapman. \nA panel discussion will follow featuring current UKDTN Clinical Trial Fellows sharing their perspectives on what it is like to be part of UKDTN and to work at the forefront of Alzheimer’s and dementia research. The webinar aims to inspire early career researchers to explore opportunities in clinical research and consider pursuing a similar path. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/ukdtn-aruk-clinical-trial-placement-pilot-programme/
LOCATION:Online\, United Kingdom
CATEGORIES:Online
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/02/UKDTN-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260708T120000
DTEND;TZID=Europe/London:20260708T124500
DTSTAMP:20260621T203155
CREATED:20260526T182147Z
LAST-MODIFIED:20260526T182147Z
UID:10002263-1783512000-1783514700@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Research Showcase - Assistive Technology and Dementia Care
DESCRIPTION:What can the UK learn from Japan about technology and dementia care. And how might robotics\, virtual reality\, smart homes\, and artificial intelligence support people living with dementia. \nThis livestream is part of the Dementia Researcher weekly Showcase series. Each week we host a 45 minute online session bringing researchers together to share their work\, methods\, and ideas. \nIn this session\, Bethany Linder will share insights from her Churchill Fellowship exploring advances in assistive dementia technology in Japan. Through visits with leading experts in robotics\, virtual reality\, and smart home technologies\, Bethany examined how one of the world’s fastest ageing populations is using technology to support people living with dementia. \nThe session will explore what has worked\, what has not worked\, and future directions in assistive technology\, alongside reflections on how lessons from Japan could help improve dementia care in the UK. \nBethany is a dementia researcher at the Nuffield Department of Primary Care Health Sciences\, University of Oxford. Her work focuses on using technology to support older adults and people affected by dementia\, including current research exploring how artificial intelligence could support medication management for people living with dementia. \nAttendees can expect a research focused session with time for questions and discussion. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/research-showcase-assistive-technology-and-dementia-care/
LOCATION:Dementia Researcher Communities App
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/05/Assistive-Technology-and-Dementia-Care-web.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260708T140000
DTEND;TZID=Europe/London:20260708T150000
DTSTAMP:20260621T203155
CREATED:20260618T205543Z
LAST-MODIFIED:20260618T205543Z
UID:10002292-1783519200-1783522800@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Making Alzheimer’s Biomarkers More Accessible
DESCRIPTION:Join this 60-minute live webinar exploring practical advances in blood-based biomarker testing for Alzheimer’s disease (AD)\, with a focus on scalable and accessible quantitation of the optimal combination of biomarkers. \nDespite rapid growth in AD biomarker research\, it is not always clear which targets are the most meaningful and which measurement system best serves a given application. Quantitation methods range from highly specialized platforms requiring significant capital investment\, to simpler approaches with lower sensitivity. \nThis session will introduce a new cost-effective and sensitive (sub-pg/mL) biomarker detection platform and present findings on an AD 5-plex biomarker panel on well-characterized clinical samples. Preliminary data on an eMTBR-tau243 and BD pTau-217 duplex available for early-access will also be presented. \nThrough a structured webinar format combining expert presentation and moderated discussion\, participants will explore: \n\nConsiderations and tradeoffs for selecting biomarker quantitation methods\nDeep-dive into scalable ultrasensitive detection without capital equipment\nThe rational for targeted biomarker panels\, including why pTau-217\, Aβ42\, Aβ40\, NfL\, and GFAP were selected.\nEvaluate targeted biomarker panel performance in well-characterized clinical samples\n\nDesigned to support scientific exchange and practical understanding\, this session will provide a first look at evolving data and its potential implications for research and clinical workflows. \nFaculty \nChair: Marissa Lee\, PhD\, Director of Applications\, Taudia\nSpeaker: Noah Elder\, Director of R&D\, Taudia \nThis webinar is delivered in collaboration with Taudia. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/making-alzheimers-biomarkers-more-accessible/
LOCATION:Online\, United Kingdom
CATEGORIES:Lecture
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/06/Making-Alzheimers-Biomarkers-More-Accessible.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260709T093000
DTEND;TZID=Europe/London:20260709T160000
DTSTAMP:20260621T203155
CREATED:20260604T172205Z
LAST-MODIFIED:20260604T172205Z
UID:10002278-1783589400-1783612800@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Creative Dementia: Sharing Good Practice Conference
DESCRIPTION:Creative Dementia Arts Network are organising this event to share best practice of the use of arts in dementia care\, alongside a book launch \n\n\n\n\nThe event\, organised by the Creative Dementia Arts Network will include a launch of The Creative Dementia Practice Handbook: Arts for Health and Wellbeing and will have many of the 24 wonderful authors attending\, some of whom will present their chapter topics or lead dance\, poetry and music workshop. We are proud to be partnered for this event with National Activity Providers Association (NAPA)\, the UK’s leading activity and engagement charity. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/creative-dementia-sharing-good-practice-conference/
LOCATION:Watershed\, 1 Canon's Road\, Bristol\, BS1 5TX\, United Kingdom
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/06/Creative-Dementia-Sharing-Good-Practice-Conference.png
GEO:51.4374324;-2.6047413
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Watershed 1 Canon's Road Bristol BS1 5TX United Kingdom;X-APPLE-RADIUS=500;X-TITLE=1 Canon's Road:geo:-2.6047413,51.4374324
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260710T080000
DTEND;TZID=Europe/London:20260710T173000
DTSTAMP:20260621T203155
CREATED:20260615T141343Z
LAST-MODIFIED:20260616T100309Z
UID:10002289-1783670400-1783704600@www.dementiaresearcher.nihr.ac.uk
SUMMARY:NIA-AA Symposium — Enabling Precision Medicine for Alzheimer’s Disease Through Open Science
DESCRIPTION:NIA AA Symposium 2026\nEnabling Precision Medicine for Alzheimer’s Disease Through Open Science\nFriday 10 July 20268.00 am to 5.30 pm BSTInterContinental London O2 Hotel\, Peninsula West\, LondonIn person attendance only \nThe 8th Annual NIA AA Symposium will bring together researchers\, clinicians\, data scientists\, open science advocates\, and industry colleagues to explore how precision medicine and open science can advance Alzheimer’s disease and related dementias research. \nHosted as an AAIC 2026 preconference\, the symposium will feature NIA supported clinical trials and translational research programmes using precision medicine approaches to better understand disease heterogeneity\, identify new targets and biomarkers\, improve models of Alzheimer’s disease\, and support therapy development. \nAcross the day\, sessions will cover molecular subtypes and shared disease mechanisms\, environmental approaches to risk reduction and prevention\, preclinical therapy development\, clinical development\, and the creation of knowledge networks for precision medicine. \nThe programme has been jointly developed by the National Institute on Aging and the Alzheimer’s Association\, with speakers from leading institutions including NIA\, Emory University\, Rush University\, Columbia University\, University of Michigan\, The Jackson Laboratory\, University of Pittsburgh\, Harvard University\, Duke University\, University of California San Francisco\, Sage Bionetworks and the Allen Institute. \nWho should attend?\nThis event is aimed at academic\, biotech and pharmaceutical industry researchers\, clinicians\, computational biologists\, data scientists\, and others with an interest in target discovery\, biomarker discovery\, drug development\, precision medicine and open science. \nRegistration\nAAIC preconferences require separate registration. Attendees may register alongside AAIC full conference registration or as a stand alone preconference event. Registration is managed by the Alzheimer’s Association.
URL:https://www.dementiaresearcher.nihr.ac.uk/event/nia-aa-symposium-enabling-precision-medicine-for-alzheimers-disease-through-open-science/
LOCATION:InterContinental London O2 Hotel\, 1 Waterview Dr\, London\, SE10 0TW\, United Kingdom
CATEGORIES:Symposium
ATTACH;FMTTYPE=image/jpeg:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2021/09/NIA-e1642070215650.jpg
GEO:51.5028854;-0.0001096
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=InterContinental London O2 Hotel 1 Waterview Dr London SE10 0TW United Kingdom;X-APPLE-RADIUS=500;X-TITLE=1 Waterview Dr:geo:-0.0001096,51.5028854
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260710T083000
DTEND;TZID=Europe/London:20260710T183000
DTSTAMP:20260621T203155
CREATED:20260515T122254Z
LAST-MODIFIED:20260515T122254Z
UID:10002246-1783672200-1783708200@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Industry MasterClass in Drug Discovery and Development
DESCRIPTION:Taking therapeutics for neurodegeneration from concept to trial \nJoin leading experts from academia\, biotech\, pharma and drug development for a practical one day MasterClass exploring how discoveries in neurodegeneration can move from early target selection through to clinical trial strategy. \nThis in person event will examine the key stages of the drug discovery and development process\, from identifying and validating targets\, discovering and optimising leads\, and navigating regulatory and commercial considerations\, through to preparing for trial delivery. \nThe programme will bring together speakers from organisations including AstraZeneca\, MSD\, Lundbeck\, AbbVie\, Novartis\, Roche\, Eisai\, Cervevance\, Isomorphic\, Denali\, AstronautX\, JNJ\, Advent\, Lilly and BMS. \nDiscussions will be hosted by Prof. Sarah Tabrizi and Prof. Mike Hanna from UCL. \nKeynote\nThe Journey from an Academic Discovery to a TrialKaterina AkassoglouGladstone Institute and Founder\, Therini Bio \nCo organisers\nFiona DucotterdAlzheimer’s Research UK UCL Drug Discovery Institute \nJim RayBelfer Neurodegeneration Consortium\, MD Anderson \nWhat will be covered\nAttendees will discuss: \n\nHow targets are selected to progress in biotech and pharma\nHow leads are discovered and optimised into therapeutics\nHow discoveries move from hit to candidate to formulation\nHow regulatory and commercial considerations are navigated\nHow to move towards a clinical trial\nHow value is created for patients\, providers and the pharmaceutical industry\nWhere the field is heading next\n\nEvent details\nDate: Friday 10 July 2026Time: 8.30 am to 6.30 pmLocation: Mary Ward House\, LondonFormat: In personCapacity: Limited places available \nWho should attend\nThis MasterClass is designed for researchers\, clinicians\, industry professionals\, funders\, translational scientists and anyone interested in how neurodegeneration therapeutics move from discovery science towards development and trial readiness. \nRegistration is now open.A practical\, high level course on translating neurodegeneration drug discovery into development strategy.
URL:https://www.dementiaresearcher.nihr.ac.uk/event/industry-masterclass-in-drug-discovery-and-development/
LOCATION:Mary Ward House\, 5 - 7 Tavistock Place\, London\, Greater London\, WC1H 9SN\, United Kingdom
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/01/UCL-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260710T100000
DTEND;TZID=Europe/London:20260710T170000
DTSTAMP:20260621T203155
CREATED:20260326T205154Z
LAST-MODIFIED:20260326T205230Z
UID:10002161-1783677600-1783702800@www.dementiaresearcher.nihr.ac.uk
SUMMARY:ITM2B Symposium
DESCRIPTION:How can an understudied gene teach us to fight dementia? The ITM2B Symposium is a research conference exploring clinical\, pathological and modelling advances in British dementia and other ITM2B related dementias. \nThis meeting brings together international experts to share the latest findings on disease mechanisms\, biomarkers\, and emerging approaches to understanding these rare but informative conditions. By focusing on ITM2B\, an often overlooked gene\, the symposium aims to uncover insights that may inform broader dementia research. \nDate and Location\n10 July 2026Kennedy Lecture Theatre\, ICH GOSH\, London\, UK \nThis is a hybrid event\, with options to attend in person or online. \nAttendance\n\nFree to attend\nOpen to all career stages and backgrounds\n\nSpeakers\n\nRuben Vidal\, Indiana University School of Medicine\, USA\nLuciano D’Adamio\, Rutgers Brain Health Institute\, USA\nSimon Mead\, UCL\, UK\nTamas Revesz\, UCL\, UK\nKo Woon Kim\, National University Hospital\, Jeonju\, South Korea\nJuliette Wohlschlegel\, University of Washington\, USA\n\nRegistration\nRegister by 10 June 2026 \nFor further information contact: c.arber@ucl.ac.uk \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/itm2b-symposium/
LOCATION:UCL – Kennedy Lecture Theatre\, Institute of Child Health - Main Building\, 30 Guildford Street\, London\, Greater London\, WC1N 1EH\, United Kingdom
CATEGORIES:Conference,Online,Symposium
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/03/ITM2B-Symposium.png
GEO:51.523309;-0.120066
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=UCL – Kennedy Lecture Theatre Institute of Child Health - Main Building 30 Guildford Street London Greater London WC1N 1EH United Kingdom;X-APPLE-RADIUS=500;X-TITLE=Institute of Child Health - Main Building\, 30 Guildford Street:geo:-0.120066,51.523309
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260712
DTEND;VALUE=DATE:20260716
DTSTAMP:20260621T203155
CREATED:20260323T220855Z
LAST-MODIFIED:20260323T220855Z
UID:10002158-1783814400-1784159999@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Alzheimer's Association International Conference
DESCRIPTION:Alzheimer’s Association International Conference® (AAIC®) 2026 — July 12-15\, in London\, U.K.\, and online\, you’re stepping into the largest global gathering of Alzheimer’s and dementia researchers\, clinicians and innovators. Last year\, more than 11\,000 attendees came together to share insights\, build partnerships and push the boundaries of what’s possible. In 2026\, that momentum continues\, and we want you there! \nWhy register now? \nAs a member of the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)\, you enjoy exclusive\, priority access designed to elevate your AAIC experience. Register now to secure early entry to limited‑capacity events and hotel accommodations\, ensuring you make the most of your time at AAIC and fully engage with the science\, experts and opportunities that matter most to you. \nRegister Early to Experience the Best of AAIC 2026 \n\n*If your attendance depends on your abstract or fellowship decision\, please wait to register or book travel until you receive an update from the Association the week of March 16. We cannot reimburse costs if you register or book travel before receiving a fellowship decision\, or if you change your attendance type after abstract notifications. Fellowship applicants who do not follow this may forfeit part or all of their award.
URL:https://www.dementiaresearcher.nihr.ac.uk/event/alzheimers-association-international-conference/
LOCATION:ExCel London\, Royal Victoria Dock\, London\, Greater London\, E16 1XL\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2025/08/AAIC-2026-Logo.png
GEO:51.5077767;0.0300599
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=ExCel London Royal Victoria Dock London Greater London E16 1XL United Kingdom;X-APPLE-RADIUS=500;X-TITLE=Royal Victoria Dock:geo:0.0300599,51.5077767
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260712
DTEND;VALUE=DATE:20260717
DTSTAMP:20260621T203155
CREATED:20260515T213123Z
LAST-MODIFIED:20260515T213123Z
UID:10002247-1783814400-1784246399@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Synergy for Science 2026
DESCRIPTION:Throughout history\, scientific endeavours have traditionally been compartmentalized into disciplines\, where like-minded researchers converge to address specific problems from a shared perspective. This approach has undeniably facilitated focused research\, hastened the pace of discoveries and contributed to the major breakthroughs of the last century. However\, an unintended consequence of this specialization has been the development of specialized languages and a sense of belonging within these disciplinary communities\, ultimately fostering impermeable knowledge silos across the entire scientific landscape.  \nWhile the establishment of disciplinary boundaries has played a crucial role in shaping our modern society\, there is now a recognized imperative to transcend these boundaries and confront the substantial challenges facing our globalized world. The emergence of interdisciplinary science represents a departure from the norm\, driven by courageous scientists eager to construct cultural bridges between disparate communities. Pioneers of interdisciplinary science have achieved remarkable results\, powered by their unique perspectives. However\, while the intersection at the heart of interdisciplinary science is inherently dynamic\, signifying its vitality\, the downside lies in its relatively modest scale. When extracted from their original environments\, interdisciplinary communities frequently struggle to attain the critical mass necessary for a lasting impact on our evolving society. \nSynSci26 will mark the inaugural conference set to take place in Glasgow in July 2026. With the subtitle “Meeting for a Healthier Future\,” this event aims to bring together diverse communities to collectively address the mandate of the third Sustainable Development Goal (SDG) outlined by the United Nations. By emphasizing collaboration and innovative approaches\, SynSci26 seeks to contribute meaningfully to the pursuit of a healthier\, more sustainable future. We invite scientists\, researchers\, and thought leaders from various disciplines to be part of this historic occasion\, breaking down barriers and shaping a brighter\, healthier world through interdisciplinary science. Together\, let us pave the way for future SynSci conferences that continue to make significant strides in addressing global challenges. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/synergy-for-science-2026/
LOCATION:Scottish Event Campus\, Exhibition Way\, Glasgow\, G3 8YW\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2021/05/British-Psychology-society.png
GEO:55.8610787;-4.2892439
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Scottish Event Campus Exhibition Way Glasgow G3 8YW United Kingdom;X-APPLE-RADIUS=500;X-TITLE=Exhibition Way:geo:-4.2892439,55.8610787
END:VEVENT
END:VCALENDAR